首页 | 本学科首页   官方微博 | 高级检索  
     


Large intercommunity difference in cardiovascular drug consumption: relation to mortality,risk factors and socioeconomic differences
Authors:M. Öreberg  G. G. Jousson  K. West  M. Eberhard-Grahn  L. Råstam  Prof. A. Melander
Affiliation:(1) Health Care Centre, Hbrby, Sweden;(2) Department of Clinical Pharmacology, University of Lund Medical Research Centre Malmö General Hospital, S-21401 Malmö, Sweden;(3) Department of Community Health Sciences, Lund University, Malmb, Sweden
Abstract:Summary A comparison of cardiovascular drug sales and cardiovascular mortality was made between two Swedish counties (Värmland and Malmöhus) and between two rural municipalities in those counties (Torsby in Värmland and Hörby in Malmöhus).Cardiovascular drug sales (defined daily doses (DDD) per 1,000 inhabitants per day) during 1986–87 were 25 higher in Vdrmland than in Malmöhus county, and the age-standardized mortality of coronary heart disease (CHD) was 36% (men) and 54% (women) higher. In Torsby, age-standardized CHD mortality (1986–87) was 71 % (both sexes) higher than in H6rby, and the sales of cardiovascular drugs (1978–87) were 58 % higher. Statistically, every third inhabitant of Torsby took one DDD of a cardiovascular drug every day, as compared to every fifth inhabitant in Hörby. In Torsby there was a 6 % higher serum cholesterol, 71 % lower tap water hardness, 33 lower income, a lower educational level, a three-fold higher unemployment rate, and a different ethnic background (20 % eastern Finnish ancestry), all factors assumed to promote a high CHD rate.All of these factors may contribute to the higher CHD mortality, which was in turn reflected in higher sales of cardiovascular drugs.
Keywords:Pharmacoepidemiology, Cardiovascular drug use, Coronary heart disease mortality  heredity, demography, cholesterol, socioeconomy
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号